132 related articles for article (PubMed ID: 31360742)
41. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection.
Ng BE; Butler LM; Horvath T; Rutherford GW
Cochrane Database Syst Rev; 2011 Mar; (3):CD001220. PubMed ID: 21412869
[TBL] [Abstract][Full Text] [Related]
42. Effect of antiretroviral therapy on the incidence of cervical neoplasia among HIV-infected women: a population-based cohort study in Taiwan.
Chen YC; Li CY; Liu HY; Lee NY; Ko WC; Ko NY
AIDS; 2014 Mar; 28(5):709-15. PubMed ID: 24326354
[TBL] [Abstract][Full Text] [Related]
43. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer.
Liu G; Sharma M; Tan N; Barnabas RV
AIDS; 2018 Mar; 32(6):795-808. PubMed ID: 29369827
[TBL] [Abstract][Full Text] [Related]
44. Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies.
Kwenti TE
Res Rep Trop Med; 2018; 9():123-136. PubMed ID: 30100779
[TBL] [Abstract][Full Text] [Related]
45. Rehabilitation approaches for children living with HIV in sub-Saharan Africa: a protocol for scoping review.
Maddocks S; Cobbing S; Hanass-Hancock J; Chetty V
Syst Rev; 2019 Dec; 8(1):336. PubMed ID: 31870410
[TBL] [Abstract][Full Text] [Related]
46. Association of antiretroviral therapy with anal high-risk human papillomavirus, anal intraepithelial neoplasia, and anal cancer in people living with HIV: a systematic review and meta-analysis.
Kelly H; Chikandiwa A; Alemany Vilches L; Palefsky JM; de Sanjose S; Mayaud P
Lancet HIV; 2020 Apr; 7(4):e262-e278. PubMed ID: 32109408
[TBL] [Abstract][Full Text] [Related]
47. Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children.
Kalyesubula I; Musoke-Mudido P; Marum L; Bagenda D; Aceng E; Ndugwa C; Olness K
Pediatr Infect Dis J; 1997 Sep; 16(9):876-81. PubMed ID: 9306483
[TBL] [Abstract][Full Text] [Related]
48. Risk of HIV infection among Dutch expatriates in sub-Saharan Africa.
Houweling H; Coutinho RA
Int J STD AIDS; 1991; 2(4):252-7. PubMed ID: 1911956
[TBL] [Abstract][Full Text] [Related]
49. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
[TBL] [Abstract][Full Text] [Related]
50. Impact of Highly Active Antiretroviral Therapy on the Natural History of Cervical Precancerous Lesions: A 17-Year Institutional Longitudinal Cohort Study.
Patrelli TS; Gizzo S; Peri F; Franchi L; Volpi L; Esposito F; Pedrazzi G; Antoni AD; Modena AB
Reprod Sci; 2014 Jul; 21(7):837-845. PubMed ID: 24336675
[TBL] [Abstract][Full Text] [Related]
51. Breast cancer, human immunodeficiency virus and highly active antiretroviral treatment; implications for a high-rate seropositive region.
Chirkut S
Oncol Rev; 2019 Jan; 13(1):376. PubMed ID: 30713605
[TBL] [Abstract][Full Text] [Related]
52. Tropical Parasitic Infections in Individuals Infected with HIV.
Evans EE; Siedner MJ
Curr Trop Med Rep; 2017 Dec; 4(4):268-280. PubMed ID: 33842194
[TBL] [Abstract][Full Text] [Related]
53. Demonstration of some of the Pathological Results of Helminthic Infections in Animals.
Leiper RT; Cameron TW
Proc R Soc Med; 1924; 17(Sect Comp Med):37. PubMed ID: 19983949
[No Abstract] [Full Text] [Related]
54. Malaria and Helminthic Co-Infection during Pregnancy in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
Tadesse Boltena M; El-Khatib Z; Kebede AS; Asamoah BO; Yaw ASC; Kamara K; Constant Assogba P; Tadesse Boltena A; Adane HT; Hailemeskel E; Biru M
Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564842
[TBL] [Abstract][Full Text] [Related]
55. Effects of malaria/helminthic coinfections on cervical cancer progression among sub Saharan African women on highly active antiretroviral therapy: A scoping review.
Menon S; Rodolfo R; Akudibillah G; Dusabimana A; Harmon S; Mabeya H
Gynecol Oncol Rep; 2019 Aug; 29():64-69. PubMed ID: 31360742
[TBL] [Abstract][Full Text] [Related]
56. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review.
Crepaz N; Hart TA; Marks G
JAMA; 2004 Jul; 292(2):224-36. PubMed ID: 15249572
[TBL] [Abstract][Full Text] [Related]
57. Malaria and helminthic co-infection among HIV-positive pregnant women: prevalence and effects of antiretroviral therapy.
Ivan E; Crowther NJ; Rucogoza AT; Osuwat LO; Munyazesa E; Mutimura E; Njunwa KJ; Zambezi KJ; Grobusch MP
Acta Trop; 2012 Dec; 124(3):179-84. PubMed ID: 22940013
[TBL] [Abstract][Full Text] [Related]
58. Public health approach to prevent cervical cancer in HIV-infected women in Kenya: Issues to consider in the design of prevention programs.
Menon S; Rossi R; Harmon SG; Mabeya H; Callens S
Gynecol Oncol Rep; 2017 Nov; 22():82-88. PubMed ID: 29159260
[TBL] [Abstract][Full Text] [Related]
59. HAART use in women with HIV and influence on cervical intraepithelial neoplasia: a clinical opinion.
Khanna N
J Low Genit Tract Dis; 2002 Apr; 6(2):111-5. PubMed ID: 17051009
[TBL] [Abstract][Full Text] [Related]
60. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa.
ter Kuile FO; Parise ME; Verhoeff FH; Udhayakumar V; Newman RD; van Eijk AM; Rogerson SJ; Steketee RW
Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):41-54. PubMed ID: 15331818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
